Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Taselisib

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Taselisib

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cancer scientist failed to disclose industry payments — does that matter?
    Cancer scientist failed to disclose industry payments — does that matter?

    10 Sep 2018

    // John Carroll ENDPTS

    https://endpts.com/a-star-cancer-scientist-failed-to-disclose-industry-payments-over-the-years-does-that-matter-so-much/

    John Carroll ENDPTS
    10 Sep 2018
    Share Share
    Novartis considers filings for PI3K drug in breast cancer
    Novartis considers filings for PI3K drug in breast cancer

    24 Aug 2018

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/novartis_considers_filings_for_pi3k_drug_in_breast_cancer_1249957

    Phil Taylor PMLIVE
    24 Aug 2018
    Share Share
    Novartis trial win lifts profile of new breast cancer drug
    Novartis trial win lifts profile of new breast cancer drug

    23 Aug 2018

    // John Miller REUTERS

    https://www.reuters.com/article/us-novartis-breast-cancer/novartis-trial-win-lifts-profile-of-new-breast-cancer-drug-idUSKCN1L80PM

    John Miller REUTERS
    23 Aug 2018
    Share Share
    Novartis just boasted of a big PhIII PI3K success
    Novartis just boasted of a big PhIII PI3K success

    23 Aug 2018

    // John Carroll ENDPTS

    https://endpts.com/novartis-just-boasted-of-a-big-phiii-pi3k-success-but-heres-why-we-should-hold-our-applause-for-now/

    John Carroll ENDPTS
    23 Aug 2018
    Share Share
    Novartis succeeds where Roche failed with PI3K breast cancer drug
    Novartis succeeds where Roche failed with PI3K breast cancer drug

    23 Aug 2018

    // Piotr Wnuk PHARMAPHORUM

    https://pharmaphorum.com/news/novartis-success-breast-cancer-inhibitor/

    Piotr Wnuk PHARMAPHORUM
    23 Aug 2018
    Share Share
    Novartis punts a late-stage PI3K drug to China’s biotechs
    Novartis punts a late-stage PI3K drug to China’s biotechs

    12 Jul 2018

    // John Carroll ENDPTS

    https://endpts.com/novartis-punts-a-late-stage-pi3k-drug-with-a-worrying-safety-profile-to-one-of-chinas-upstart-biotechs/

    John Carroll ENDPTS
    12 Jul 2018
    Share Share